INDIE SEMICONDUCTOR INC-A (INDI)

US45569U1016 - Common Stock

5.97  +0.16 (+2.75%)

After market: 5.97 0 (0%)

Fundamental Rating

2

Overall INDI gets a fundamental rating of 2 out of 10. We evaluated INDI against 107 industry peers in the Semiconductors & Semiconductor Equipment industry. INDI has a bad profitability rating. Also its financial health evaluation is rather negative. INDI is valued quite expensively, but it does show have an excellent growth rating.



0

1. Profitability

1.1 Basic Checks

INDI had negative earnings in the past year.
INDI had a negative operating cash flow in the past year.
INDI had negative earnings in each of the past 5 years.
In the past 5 years INDI always reported negative operating cash flow.

1.2 Ratios

INDI has a Return On Assets of -14.37%. This is in the lower half of the industry: INDI underperforms 76.42% of its industry peers.
INDI has a worse Return On Equity (-26.37%) than 73.58% of its industry peers.
Industry RankSector Rank
ROA -14.37%
ROE -26.37%
ROIC N/A
ROA(3y)-13.41%
ROA(5y)-82.76%
ROE(3y)-22.78%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

With a Gross Margin value of 40.13%, INDI is not doing good in the industry: 61.32% of the companies in the same industry are doing better.
INDI's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for INDI so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 40.13%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.88%
GM growth 5YN/A

2

2. Health

2.1 Basic Checks

INDI does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for INDI has been increased compared to 1 year ago.
The debt/assets ratio for INDI has been reduced compared to a year ago.

2.2 Solvency

Based on the Altman-Z score of 1.10, we must say that INDI is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of INDI (1.10) is worse than 74.53% of its industry peers.
A Debt/Equity ratio of 0.35 indicates that INDI is not too dependend on debt financing.
INDI's Debt to Equity ratio of 0.35 is on the low side compared to the rest of the industry. INDI is outperformed by 63.21% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.35
Debt/FCF N/A
Altman-Z 1.1
ROIC/WACCN/A
WACC12.18%

2.3 Liquidity

A Current Ratio of 1.96 indicates that INDI should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.96, INDI is doing worse than 72.64% of the companies in the same industry.
INDI has a Quick Ratio of 1.72. This is a normal value and indicates that INDI is financially healthy and should not expect problems in meeting its short term obligations.
INDI has a Quick ratio of 1.72. This is in the lower half of the industry: INDI underperforms 64.15% of its industry peers.
Industry RankSector Rank
Current Ratio 1.96
Quick Ratio 1.72

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 32.56% over the past year.
INDI shows a strong growth in Revenue. In the last year, the Revenue has grown by 101.40%.
Measured over the past years, INDI shows a very strong growth in Revenue. The Revenue has been growing by 114.54% on average per year.
EPS 1Y (TTM)32.56%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q90.91%
Revenue 1Y (TTM)101.4%
Revenue growth 3Y114.54%
Revenue growth 5YN/A
Revenue growth Q2Q112.33%

3.2 Future

The Earnings Per Share is expected to grow by 51.67% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 33.37% on average over the next years. This is a very strong growth
EPS Next Y36.29%
EPS Next 2Y60.07%
EPS Next 3Y51.67%
EPS Next 5YN/A
Revenue Next Year25.4%
Revenue Next 2Y36.37%
Revenue Next 3Y33.37%
Revenue Next 5YN/A

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for INDI. In the last year negative earnings were reported.
Also next year INDI is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

A more expensive valuation may be justified as INDI's earnings are expected to grow with 51.67% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y60.07%
EPS Next 3Y51.67%

0

5. Dividend

5.1 Amount

INDI does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

INDIE SEMICONDUCTOR INC-A

NASDAQ:INDI (5/3/2024, 7:00:02 PM)

After market: 5.97 0 (0%)

5.97

+0.16 (+2.75%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap1.11B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -14.37%
ROE -26.37%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 40.13%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.27
Health
Industry RankSector Rank
Debt/Equity 0.35
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.96
Quick Ratio 1.72
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)32.56%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y36.29%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)101.4%
Revenue growth 3Y114.54%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y